Ahn-Gook Pharmaceuticals Co.,Ltd   Report issue

For profit Phase 1 Phase 3 Phase 4
Founded: Hwaseong Korea, Republic of (1955)
Status: No NME R&D (1955)

Organization Overview

First Clinical Trial
2006
NCT00380315
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Ahn-Gook Pharmaceuticals Co.,Ltd

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Disease (Phase 4)

Bronchitis (Phase 4)

Bronchitis, Chronic (Phase 4)

Cough (Phase 3)

Esophagitis, Peptic (Phase 3)

Essential Hypertension (Phase 3)

Gastroesophageal Reflux (Phase 3)

Hypertension (Phase 3)

Infections (Phase 3)

Respiratory Tract Infections (Phase 3)

Rhinitis (Phase 3)

Rhinitis, Allergic (Phase 3)

Rhinitis, Allergic, Perennial (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 16
  • # of Trial APIs: 19